Posted inNeurology ALXN1840 Phase 3 Breakthrough: Shifting Wilson Disease Care from Copper Control to Neurologic Recovery Posted by By Zhang Paul 11/21/2026 A new subgroup analysis from the Phase 3 FoCus trial (NCT03403205) marks a major turning…